Gary W. McCollum

1.3k total citations
46 papers, 1.1k citations indexed

About

Gary W. McCollum is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gary W. McCollum has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Ophthalmology, 23 papers in Molecular Biology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gary W. McCollum's work include Retinal Diseases and Treatments (21 papers), Retinopathy of Prematurity Studies (7 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Gary W. McCollum is often cited by papers focused on Retinal Diseases and Treatments (21 papers), Retinopathy of Prematurity Studies (7 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Gary W. McCollum collaborates with scholars based in United States and Switzerland. Gary W. McCollum's co-authors include John S. Penn, Raymond F. Burk, Kristina E. Hill, Megan E. Capozzi, Martha E. Boeglin, Joshua M. Barnett, George W. Kabalka, Veera Rajaratnam, Xiang Q. Werdich and Sara R. Savage and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Analytical Biochemistry.

In The Last Decade

Gary W. McCollum

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary W. McCollum United States 20 539 321 206 200 114 46 1.1k
Masatoshi Tomi Japan 29 771 1.4× 234 0.7× 85 0.4× 84 0.4× 486 4.3× 87 2.2k
Ashima Bhattacharjee India 16 284 0.5× 244 0.8× 487 2.4× 100 0.5× 18 0.2× 28 998
Xingjun Fan United States 22 661 1.2× 143 0.4× 97 0.5× 58 0.3× 64 0.6× 46 1.1k
Guey‐Shuang Wu United States 22 329 0.6× 521 1.6× 38 0.2× 122 0.6× 54 0.5× 46 1.1k
Mikhail Linetsky United States 21 736 1.4× 165 0.5× 43 0.2× 71 0.4× 65 0.6× 43 1.2k
Sailaja Elchuri India 17 766 1.4× 88 0.3× 77 0.4× 46 0.2× 32 0.3× 38 1.3k
Heidi R. Vollmer-Snarr United States 12 806 1.5× 733 2.3× 31 0.2× 156 0.8× 26 0.2× 17 1.1k
Hassan Sellak United States 19 682 1.3× 42 0.1× 60 0.3× 40 0.2× 154 1.4× 36 1.5k
Marta Ugarte United Kingdom 16 639 1.2× 549 1.7× 219 1.1× 215 1.1× 19 0.2× 33 1.3k
Ayşegül Çört Türkiye 15 291 0.5× 109 0.3× 54 0.3× 50 0.3× 30 0.3× 25 658

Countries citing papers authored by Gary W. McCollum

Since Specialization
Citations

This map shows the geographic impact of Gary W. McCollum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. McCollum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. McCollum more than expected).

Fields of papers citing papers by Gary W. McCollum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary W. McCollum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. McCollum. The network helps show where Gary W. McCollum may publish in the future.

Co-authorship network of co-authors of Gary W. McCollum

This figure shows the co-authorship network connecting the top 25 collaborators of Gary W. McCollum. A scholar is included among the top collaborators of Gary W. McCollum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary W. McCollum. Gary W. McCollum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
McCollum, Gary W., et al.. (2024). Role of NLRP3 Inflammasomes in Monocyte and Microglial Recruitments in Choroidal Neovascularization. ImmunoHorizons. 8(5). 363–370. 2 indexed citations
3.
McCollum, Gary W., et al.. (2024). Imaging Hypoxia to Predict Primary Neuronal Cell Damage in Branch Retinal Artery Occlusion. Microcirculation. 31(7). e12883–e12883.
4.
Yang, Rong, et al.. (2021). 5,6-epoxyeicosatrienoic acid ethanolamide endocannabinoid mitigates diabetes-induced retinal vascular inflammation. Investigative Ophthalmology & Visual Science. 62(8). 2926–2926. 1 indexed citations
5.
Kim, Minjae, et al.. (2021). Cannabinoid Receptor 2 Agonist HU-308 Demonstrates Therapeutic Potential in Inflammatory Diabetic Retinopathy Models. Investigative Ophthalmology & Visual Science. 62(8). 3012–3012. 2 indexed citations
6.
Kim, Minjae, et al.. (2021). Nuclear factor of activated T-cells (NFAT) regulation of IL-1β-induced retinal vascular inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(12). 166238–166238. 26 indexed citations
7.
8.
Uddin, Md. Imam, et al.. (2017). Real-time imaging of VCAM-1 mRNA in TNF- α activated retinal microvascular endothelial cells using antisense hairpin-DNA functionalized gold nanoparticles. Nanomedicine Nanotechnology Biology and Medicine. 14(1). 63–71. 17 indexed citations
9.
Capozzi, Megan E., et al.. (2016). Linoleic Acid is a Diabetes-relevant Stimulator of Retinal Inflammation in Human Retinal Muller Cells and Microvascular Endothelial Cells. Journal of Diabetes & Metabolism. 7(11). 27 indexed citations
10.
Capozzi, Megan E., Sandra S. Hammer, Gary W. McCollum, & John S. Penn. (2016). Epoxygenated Fatty Acids Inhibit Retinal Vascular Inflammation. Scientific Reports. 6(1). 39211–39211. 40 indexed citations
11.
Orozco‐Suárez, Sandra, Gary W. McCollum, Ashwath Jayagopal, & John S. Penn. (2015). High Glucose-induced Retinal Pericyte Apoptosis Depends on Association of GAPDH and Siah1. Journal of Biological Chemistry. 290(47). 28311–28320. 28 indexed citations
12.
McCollum, Gary W., et al.. (2014). Modulation of VEGF-Induced Retinal Vascular Permeability by Peroxisome Proliferator-Activated Receptor- / . Investigative Ophthalmology & Visual Science. 55(12). 8232–8240. 39 indexed citations
13.
Barnett, Joshua M., Gary W. McCollum, & John S. Penn. (2010). Role of Cytosolic Phospholipase A2in Retinal Neovascularization. Investigative Ophthalmology & Visual Science. 51(2). 1136–1136. 44 indexed citations
14.
Yang, Rui, et al.. (2005). The Effect of Anecortave Acetate on VEGF Message and Protein Levels in Hypoxic Müller Cells and in Rat OIR. Investigative Ophthalmology & Visual Science. 46(13). 4177–4177. 2 indexed citations
15.
Barnett, Joshua M., et al.. (2005). Hypoxia–Induced COX–2 Translocation: In vivo and in vitro Studies. Investigative Ophthalmology & Visual Science. 46(13). 4188–4188. 1 indexed citations
16.
Song, Qixue, et al.. (2005). Nepafenac Metabolite, Amfenac, Inhibits VEGF Induced Phosphorylation of ERK in Human Retinal Microvascular Endothelial Cells. Investigative Ophthalmology & Visual Science. 46(13). 4204–4204. 3 indexed citations
17.
Penn, John S., et al.. (2005). Angiostatic Effect of Penetrating Ocular Injury: Role of Pigment Epithelium-Derived Factor. Investigative Ophthalmology & Visual Science. 47(1). 405–405. 26 indexed citations
18.
Chen, Jin, Donna J. Hicks, Dana M. Brantley‐Sieders, et al.. (2005). Inhibition of retinal neovascularization by soluble EphA2 receptor. Experimental Eye Research. 82(4). 664–673. 57 indexed citations
19.
Yang, Ruifeng, et al.. (2004). Inhibition Of VEGF–Induced Endothelial Cell Poliferation And Differentiation By Steroidal And Non–steroidal Cox Inhibitors With Variable Cox–1/Cox–2 Selectivity. Investigative Ophthalmology & Visual Science. 45(13). 1914–1914. 1 indexed citations
20.
Hill, Kristina E., Gary W. McCollum, & Raymond F. Burk. (1997). Determination of Thioredoxin Reductase Activity in Rat Liver Supernatant. Analytical Biochemistry. 253(1). 123–125. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masatoshi Tomi Breakdown of academic impact, for papers by Ashima Bhattacharjee Breakdown of academic impact, for papers by Xingjun Fan Breakdown of academic impact, for papers by Guey‐Shuang Wu Breakdown of academic impact, for papers by Mikhail Linetsky Breakdown of academic impact, for papers by Sailaja Elchuri Breakdown of academic impact, for papers by Heidi R. Vollmer-Snarr Breakdown of academic impact, for papers by Hassan Sellak Breakdown of academic impact, for papers by Marta Ugarte Breakdown of academic impact, for papers by Ayşegül Çört
Rankless by CCL
2026